These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23994419)

  • 81. Gastrointestinal bleeding in patients with ventricular assist devices is highest immediately after implantation.
    French JB; Pamboukian SV; George JF; Smallfield GB; Tallaj JA; Brown RN; Smallfield MC; Kirklin JK; Holman WL; Peter S
    ASAIO J; 2013; 59(5):480-5. PubMed ID: 23995990
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Outcomes of Adult Patients with Small Body Size Supported with a Continuous-Flow Left Ventricular Assist Device.
    Lee S; Katz JN; Jorde UP; Moazami N; John R; Sundareswaran KS; Farrar DJ; Frazier OH
    ASAIO J; 2016; 62(6):646-651. PubMed ID: 27556150
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Experience with the HeartMate II Left Ventricular Assist Device in Patients Older than 60 Years.
    Demirozu ZT; Critsinelis A; Cohn WE; Radovancevic R; Ho J; Hernandez R; Morgan JA; Frazier OH
    Heart Surg Forum; 2019 Mar; 22(2):E124-E130. PubMed ID: 31013222
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
    Cleveland JC; Grover FL; Fullerton DA; Campbell DN; Mitchell MB; Lindenfeld J; Wolfel EE; Lowes BD; Shakar SF; Brieke A; Cannon A; Robertson AD
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):774-7. PubMed ID: 18805284
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: a community hospital experience.
    Adamson RM; Stahovich M; Chillcott S; Baradarian S; Chammas J; Jaski B; Hoagland P; Dembitsky W
    J Am Coll Cardiol; 2011 Jun; 57(25):2487-95. PubMed ID: 21679851
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures.
    Pal JD; Klodell CT; John R; Pagani FD; Rogers JG; Farrar DJ; Milano CA;
    Circulation; 2009 Sep; 120(11 Suppl):S215-9. PubMed ID: 19752370
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Is there a difference in bleeding after left ventricular assist device implant: centrifugal versus axial?
    Gaffey AC; Chen CW; Chung JJ; Han J; Bermudez CA; Wald J; Atluri P
    J Cardiothorac Surg; 2018 Feb; 13(1):22. PubMed ID: 29433532
    [TBL] [Abstract][Full Text] [Related]  

  • 89. HeartMate II left ventricular assist device; early European experience.
    Strüber M; Sander K; Lahpor J; Ahn H; Litzler PY; Drakos SG; Musumeci F; Schlensak C; Friedrich I; Gustafsson R; Oertel F; Leprince P
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):289-94. PubMed ID: 18571932
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Low stroke rate and few thrombo-embolic events after HeartMate II implantation under mild anticoagulation.
    Menon AK; Götzenich A; Sassmannshausen H; Haushofer M; Autschbach R; Spillner JW
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):319-23; discussion 323. PubMed ID: 22398471
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Von Willebrand factor, a versatile player in gastrointestinal bleeding in left ventricular assist device recipients?
    Fischer Q; Huisse MG; Voiriot G; Caron C; Lepage L; Dilly MP; Nataf P; Ajzenberg N; Kirsch M
    Transfusion; 2015 Jan; 55(1):51-4. PubMed ID: 25052086
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Initial clinical experience with the HeartWare left ventricular assist system: a single-center report.
    Dell'Aquila AM; Schneider SR; Schlarb D; Redwan B; Sindermann JR; Ellger B; Stypmann J; Tjan TD; Scheld HH; Hoffmeier A
    Ann Thorac Surg; 2013 Jan; 95(1):170-7. PubMed ID: 23141906
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Clinical outcomes after ventricular assist device implantation in adults with complex congenital heart disease.
    Shah NR; Lam WW; Rodriguez FH; Ermis PR; Simpson L; Frazier OH; Franklin WJ; Parekh DR
    J Heart Lung Transplant; 2013 Jun; 32(6):615-20. PubMed ID: 23540399
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Safety of reduced anti-thrombotic strategies in HeartMate II patients: A one-year analysis of the US-TRACE Study.
    Katz JN; Adamson RM; John R; Tatooles A; Sundareswaran K; Kallel F; Farrar DJ; Jorde UP;
    J Heart Lung Transplant; 2015 Dec; 34(12):1542-8. PubMed ID: 26277569
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality.
    Moazami N; Milano CA; John R; Sun B; Adamson RM; Pagani FD; Smedira N; Slaughter MS; Farrar DJ; Frazier OH;
    Ann Thorac Surg; 2013 Feb; 95(2):500-5. PubMed ID: 23261114
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation.
    Stulak JM; Deo S; Schirger J; Aaronson KD; Park SJ; Joyce LD; Daly RC; Pagani FD
    Ann Thorac Surg; 2013 Dec; 96(6):2161-7. PubMed ID: 24035302
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
    Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
    J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol.
    Pamboukian SV; Tallaj JA; Brown RN; Holman WL; Blood M; George JF; Costanzo MR; Cadeiras M; Smallfield MC; McGiffin DC; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):879-87. PubMed ID: 21514180
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Gastrointestinal Bleeding during Continuous-Flow Left Ventricular Assist Device Support is Associated with Lower Rates of Cardiac Transplantation.
    Holley CT; Harvey L; Roy SS; Cogswell R; Eckman P; Liao K; John R
    ASAIO J; 2015; 61(6):635-9. PubMed ID: 26366686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.